Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Mucosal Immunization for Recurrent UTIs
NCT00261248Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Nov 1996
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Solco-Urovac in urinary tract infection (UTI) (2 arms), sponsored by University of Wisconsin–Madison. Primary endpoint: Rate of re-infection over the study at 6 months. Started Nov 1996; status: completed.
02
Drugs
Solco-Urovac
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT00261248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00261248.